Journal article
Sclerotherapy for lower limb telangiectasias
Abstract
BACKGROUND: Sclerotherapy has been used in clinical practice for centuries, but there is still no consensus about which, if any, sclerosing agent provides the best results.
OBJECTIVES: To assess the effectiveness and safety of sclerosing agents in the treatment of telangiectasias of the lower limbs.
Authors
Schwartz L; Maxwell H
Journal
Cochrane Database of Systematic Reviews, Vol. 2021, No. 12,
Publisher
Wiley
DOI
10.1002/14651858.cd008826.pub2
ISSN
1361-6137